DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Gonçalves A, Gilabert M, François E et al.
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.
Ann Oncol 2012;
23: 2799-2805
We do not assume any responsibility for the contents of the web pages of other providers.